Eledon Pharmaceuticals, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 09/30/24 | FY 06/30/24 | FY 03/31/24 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Net income | -$45.6 | -$36.2 | — | — | — |
| Balance Sheet | |||||
| Total debt | $0.0 | $0.0 | — | — | — |
Shares outstanding 77.2M · Free float 86.3%
Annual filing data through FY ended December 31, 2025; float as of August 27, 2026.